Journals / Gülhane Tıp Dergisi / 2013 / Cilt: 55 - Sayı: 2

Evaluation of routine tranexamic acid use in cardiac surgery

Kalp cerrahisinde rutin traneksamik asit kullanımının değerlendirilmesi

Pages
111–116
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We believe that tranexamic asid use in cardiac surgery is safe.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The study is a prospective, randomized, controlled study.
📊
Key Findings & Data:Tranexamic acid use decreased postoperative blood loss, time to extubation and time to remove drainage tubes.
💡
Conclusion & Impact:We believe that tranexamic asid use in cardiac surgery is safe.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The study is a prospective, randomized, controlled study. The aim of this study is to evaluate the effects of routine tranexamic acid use on postoperative blood loss; renal, pulmonary and neurologic functions; intensive care unit and postoperative hospital length of stay in cardiac surgery. One hundred and fifty patients were randomized into two groups in a single center. Second group received tranexamic acid following protamine use after weaning from cardiopulmonary bypass whereas first group did not. Tranexamic acid use decreased postoperative blood loss, time to extubation and time to remove drainage tubes. There was no significant adverse effect on postoperative renal, pulmonary and neurologic functions. Decrease in postoperative blood loss and time to extubation allowed the drainage tubes be removed earlier. This increased patient comfort and decreased postoperative pain allowed earlier mobilisation. We did not observe any neurological complications mentioned in some other studies. We believe that tranexamic asid use in cardiac surgery is safe.

Özet

Yapılan çalışma prospektif, randomize, kontrollü bir çalışmadır. Bu çalışmada amaç, kalp cerrahisinde rutin traneksamik asit rutin kullanımının kanama miktarı, böbrek fonksiyonları, pulmoner fonksiyonlar, nörolojik durum, yoğun bakım ve hastanede kalış süreleri üzerine olan etkilerini araştırmaktır. Tek merkezde toplam 150 hasta randomize şekilde iki gruba ayrılarak ikinci gruba kardiyopulmoner baypas çıkışında protamin uygulanmasını takiben rutin traneksamik asit verilmiş, birinci gruba ise verilmemiştir. Traneksamik asit kullanımı postoperatif kanama miktarı, entübasyon süresi ve drenlerin kalış süresinde belirgin azalma sağlamıştır. Postoperatif pulmoner fonksiyonlar, böbrek fonksiyonları ve nörolojik fonksiyonlar üzerinde olumsuz bir etki gözlenmemiştir. Kanama miktarında azalma ve entübasyon süresinde kısalma drenaj tüplerinin erken çekilebilmesine olanak sağlamış, bu da hastaların postoperatif konforunu arttırmış, ağrıyı azaltmış, erken mobilizasyona olanak sağlamıştır. Diğer çalışmalarda traneksamik asit kullanımı ile ilişkilendirilen nörolojik komplikasyonlar bizim çalışmamızda görülmemiştir. Biz kalp cerrahisinde traneksamik asit güvenli olduğunu düşünmekteyiz.

🔖

Cite This Article

GÜRBÜZ, H. A., DURUKAN, A. B., TAVLAŞOĞLU, M., SALMAN, N., DURUKAN, E., SERTER, F. T., UÇAR, H. İ., YORGANCIOĞLU, C. (2013). Evaluation of routine tranexamic acid use in cardiac surgery. Gülhane Tıp Dergisi, Cilt: 55 - Sayı: 2, 111–116. https://ajindex.com/articles/216201

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Karski JM, Teasdale SJ, Norman P. et al. Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. J Thorac Cardiovasc Surg 1995; 110: 835-842
  2. Sood N, Coleman CI, Kluger J, White CM, Padala A, Baker WL. The Association Among Blood Transfusions, White Blood Cell Count, and the Frequency of Post- Cardiothoracic Surgery Atrial Fibrillation: A nested cohort study from the atrial fibrillation suppression trials I, II, and III. J Cardiothorac Vasc Anesth 2009; 23: 22-27
  3. Warren OJ, Smith AJ, Alexiou C, et al. The inflammatory response to cardiopulmonary bypass: Part 1-Mechanisms of pathogenesis. J Cardiothorac Vasc Anesth 2009; 23: 223-231
  4. Nuttall GA, Gutierrez MC, Dewey JD, et al. A preliminary study of a new tranexamic acid dosing schedule for cardiac surgery. J Cardio Vasc Anesth 2008;22:230-235
  5. Karski JM, Dowd NP, Joiner R, et al. The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 oC). J Cardiothoracic and Vascular Anesthesia 1998; 12: 642-646
  6. Spegar J, Vanek T, Snircova J, et al. Local and systemic application of tranexamic acid in heart valve surgery: A prospective, randomized, double blind LOST study. J Thromb Thrombolysis 2011; 32: 303-310
  7. Murkin JM, Falter F, Granton J, et al. High-Dose Tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010; 110: 350-353
  8. Manji RA, Grocott HP, Leake J, et al. Seizures following cardiac surgery: The impact of tranexamic acid and other risk factors. Can J Anaesth 2012; 59: 6-13
  9. Kalavrouzitis D, Voisine P, Mohammadi S, Dionne S, Dagenais F. High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg 2012; 93: 148-154
  10. Imbesi S, Nettis E, Minciullo PL, et al. Hypersensitivity to tranexamic acid: A wide spectrum of adverse reactions. Pharm. World Sci 2010; 32: 416-419
  11. Jimenez JJ, Iribarren JL, Lorente L, et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: A case control study followed by a randomized double-blind controlled trial. Critical Care 2007; 11: 1-10
  12. Jimenez JJ, Iribarren JL, Brouard M, et al. Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflamatory response in elective cardiopulmonary bypass patients: A randomized double-blind, dose-dependent, phase